全球上市药品筛选系统

药智全球上市药品筛选系统综合了中国、美国、欧盟EMA、欧盟HMA、日本、英国、法国、德国、加拿大、中国台湾省等目前世界上主流国家或地区的上市药品数据。本筛选系统以中英文活性成分、剂型、ATC、靶点四个检索项为基点，多个筛选条件为辅助，从全球上市药品剂型布局、药品活性成分的批准历程、活性成分对应的商品销售额、靶点分散图等多个维度散射，提供丰富、全面的全球上市药品综合性筛选系统。

The Yaozhi Global Marketed Drugs Screening System integrates marketed drug data from major global countries and regions, including China, the United States, the European Medicines Agency (EMA), the European Heads of Medicines Agencies (HMA), Japan, the United Kingdom, France, Germany, Canada, and Taiwan, China. Built on four core search parameters—active ingredients (supported by both Chinese and English), dosage forms, ATC codes, and drug targets—and supplemented by multiple additional screening criteria, this system enables multi-dimensional analysis covering the dosage form distribution of global marketed drugs, the approval history of active ingredients, the commercial sales of corresponding active ingredients, and drug target distribution maps, providing a rich and comprehensive platform for comprehensive screening of global marketed drugs.